Cite
HARVARD Citation
Wannick, M. et al. (2018). Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases. Pharmacology research & perspectives. 6 (6), p. n/a. [Online].